University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
NCT Number: NCT01420263
The purpose of this study is to determine whether re-feeding of gastric residuals reduces the time needed to establish full enteral feedings in premature infants. Infants with gestational ages 23-28 weeks at birth will be randomized within one week to receive either gastric residuals or fresh formula or breastmilk whenever significant residuals during feeding advancement require clinical assessment for continuing feedings. Primary outcome measure is time to establish full enteral feedings (120cc/kg/day).
Looking for future studies?
Notify Me1 day–7 day
All sexes
Interventional
Not applicable
Birmingham, Alabama, 35249, United States
Infants with gestational ages 23-28 weeks at birth will be randomized within one week to receive either gastric residuals or fresh formula or breastmilk whenever significant residuals during feeding advancement require clinical assessment for continuing feedings. Feeding advancement determined by clinical physicians.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the presence of significant gastric residuals (more than 1/3 of previous feed or > 2ml), residual volumes will be re-fed if the physician decision is to continue feeds as scheduled in the absence of other clinical signs and symptoms of feeding intolerance. This practice will be continued until full enteral feeding is achieved and maintained for a minimum of 48 hours.
In the presence of significant gastric residuals (more than 1/3 of previous feed or > 2ml), residual volumes will be discarded and fresh breastmilk or formula will be fed if the physician decision is to continue feeds as scheduled in the absence of other clinical signs and symptoms of feeding intolerance. This practice will be continued until full enteral feeding is achieved and maintained for a minimum of 48 hours.
Time frame: Birth to 28 days
Time required to reach enteral feeding at 120cc/kg/day
Time frame: Birth to 28 days
Feeding intolerance defined as interruption or cessation of enteral feeds for a perod greater than 12 hours for presence of bloody gastric residuals or an abnormal abdominal examination.
Time frame: Birth to 28 days
Number of episodes of feeding intolerance resulting in an interruption or cessation of progression of enteral feedings for a period of < 12 hours.
Time frame: Birth to 28 days
Total number of days or partial day receiving parenteral nutrition
Time frame: Birth to 120 days or discharge, whichever occurs first.
Length of hospital stay in days
Time frame: Birth to 120 days or discharge, whichever occurs first.
Diagnosis of necrotizing enterocolitis, Bell's Staging II-IV
Time frame: Birth to 120 days or discharge, whichever occurs first
Diagnosis of intestinal perforation between birth and 120 days or discharge, whichever occurs first.
Time frame: Birth to 120 days
Death prior to 121 days of age.
University of Alabama at Birmingham
Other
Re-feeding Residuals Versus Feeding Fresh Formula/Milk for Feeding Intolerance in Premature Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04337710
Enteral Feeding Intolerance, Female Urogenital Diseases and Pregnancy Complications
Birmingham, Alabama, United States
View Trial DetailsNCT05845684
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Samsun, Atakum, Turkey (Türkiye)
View Trial DetailsNCT02915549
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Birmingham, Alabama, United States
View Trial DetailsNCT01121523
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Hershey, Pennsylvania, United States
View Trial Details